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The indifferent mammalian embryonic gonad generates an ovary or testis, but the factors
involved are still poorly known. The Wnt-4 signal represents one critical female determinant,
since its absence leads to partial female-to-male sex reversal in mouse, but its signalling is as well
implicated in the testis development. We used the Wnt-4 deﬁcient mouse as a model to identify
candidate gonadogenesis genes, and found that the Notum, Phlda2, Runx-1 and Msx1 genes are
typical of the wild-type ovary and the Osr2, Dach2, Pitx2 and Tacr3 genes of the testis. Strikingly,
the expression of these latter genes becomes reversed in theWnt-4 knock-out ovary, suggesting a
role in ovarian development. We identiﬁed the transcription factor Runx-1 as a Wnt-4 signalling
target gene, since it is expressed in the ovary and is reduced upon Wnt-4 knock-out. Consistent
with this, introduction of the Wnt-4 signal into early ovary cells ex vivo induces Runx-1
expression, while conversely Wnt-4 expression is down-regulated in the absence of Runx-1. We
conclude that the Runx-1 gene can be a Wnt-4 signalling target, and that Runx-1 and Wnt-4 are
mutually interdependent in their expression. The changes in gene expression due to the absence
of Wnt-4 in gonads reﬂect the sexually dimorphic role of this signal and its complex gene
network in mammalian gonad development.
& 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).lsevier Inc. This is an open access article under the CC BY-NC-ND license
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The early gonad in mammals is initially sexually indifferent, the
primordium developed at around mid-gestation (E10) in the
mouse and is derived from the intermediate mesodermal cells.
Once formed, it attracts the germ cells which generate the
primordial germ cells through migration from the base of the
allantois towards the gonad. Around one day later (E11.0) the
indifferent gonad is gradually being assigned to follow either the
male or female sexual differentiation pathway, although the
execution of this programme is still poorly characterized.
Certain genes which are critical for sex determination have
been identiﬁed. For example, Emx2 (Empty spiracles homologue 2),
Wt1 (Wilm's tumour homologue 1), and Sf1 (Steroidogenic factor 1)
[1] are critical for the differentiation of somatic cells. Once the key
male determinant Sry (Sex determining region of Y chromosome)
becomes activated at around E11.0 [2], this transcription factor
triggers the testis development programme via its downstream
target genes such as Sox9 (Sry-like HMG protein 9), [3], which up-
regulates an early response in the gene expression of Fgf9
(Fibroblast growth factor 9), [4].
It was thought initially that the female sexual developmental
pathway represents a default alternative for the situation in which
Sry is not activated. The evidence obtained in recent years has
indicated that female sexual commitment also depends on active
cell–cell signalling that involves such secreted factors as Wnt-4
and R-spondin1 [5,6]. This conclusion has been based in part
on the fact that the female embryo undergoes a partial female-to-
male sex reversal in the absence of these factors [5,6]. Besides
suppressing the fate of the Leydig cells, the associated testo-
sterone synthesis genes [7] and the development of the Müllerian
duct [5], Wnt-4 also controls the initiation of meiosis in female
germ cells [8].
Even though Wnt-4 is a critical signal for ovarian development,
it may also have a role in the organogenesis of the testis [9]. In
synergy with Rspo1, Wnt-4 controls proliferation of the coelom
epithelial cells in the early testis affecting the number of
differentiated Sertoli cells [10]. Other than that the roles of
Wnt-4 in male and female gonad development remain open.
To achieve a more comprehensive view of the molecular mechan-
isms of mammalian sex determination and early gonad organogen-
esis, genome-wide technologies such as microarrays have been used
[11–20,21]. To study the roles of Wnt-4 in the ovarian vasculature
[18] and in the differentiation of granulosa cells [19] such method
was carried on, although the molecular mechanisms by which Wnt-
4 controls early sexual development remain poorly characterized.
We adopted the genome-wide microarray approach and the Wnt-
4 knock-out model to describe a panel of genes which can be
considered candidates for the control of early female and male sex
organogenesis. We found that the Notum, Phlda2, Runx1 and Msx1
genes appear to be typical of early wild-type ovaries, while the Osr2,
Dach2, Pitx2 and Tacr3 genes point to a testicular fate. The expression
of these genes is notably reversed in the absence of Wnt-4 function
in the ovaries. Our result also showed that Runx-1 in particular
represents a target gene for Wnt-4 signalling, but its function is also
necessary for Wnt-4 expression, depicting a positive feedback
signalling loop between these factors that advances ovary develop-
ment. This ﬁnding led us to conclude that a panel of genes regulated
by Wnt-4 signalling is expressed in a sexually dimorphic mannerduring the early stages of female sexual development. Moreover, the
data support the conclusion thatWnt-4 has a separate role in males,
that of controlling organogenesis in the testis.Materials and methods
Mouse lines
The Wnt-4 (Wnt-4/), Runx-1, and Tie2Cre;Runx1Rev/Rev knock-
out mouse models were crossed, sexed and genotyped as reported
[5,22,23]. The gonads of wild-type (WT, Wnt-4þ/þ) littermate
embryos served as controls throughout the study. All the experi-
ments involving mice were approved as being in accordance with
the Finnish national legislation, the European Convention ETS 123
and the EU Directive 86/609/EEC.
RNA extraction, microarray and quantitative real-time PCR
Ovaries and testes were prepared from embryos obtained from the
Wnt-4þ/ heterozygous mouse intercrosses. Gonads derived from
female or male embryos were used after sexing and genotyping the
embryos. Only gonads derived from Wnt-4/ or WT embryos
without the mesonephros were used. The ovaries and testes were
pooled separately, frozen immediately in liquid nitrogen, and
stored at 70 1C until used for RNA puriﬁcation with an RNeasy
kit (Qiagen). Eight pairs of gonads of each sex were prepared at
E12.5 and six at E14.5. The probability to generate mutant males
and females in a litter coming from two heterozygote crossing is of
25% (Mendellian ratio). Due to this reason, we pooled 8 mutants
together from different litters to be able to have the correct amount
of starting material at E12.5. The same was done for E14.5. Three
sets of independent biological RNA samples were hybridized with
microarray gene chips, which were performed according to the
instructions in the Affymetrix Gene Chip technical manual.
Embryonic gonad-derived RNA (8 mg) was used as the template
for synthesizing double-stranded DNA generated from the RNA by
means of a one-cycle cDNA synthesis kit (Affymetrix) and T7-(dT)
24 primers. This in vitro DNA was puriﬁed with the Gene Chip
sample cleanup module (Qiagen).
Biotin-labelled cRNA probes were generated by in vitro transcription
with the Affymetrix IVT labelling kit as suggested by the manufacturer
were used for analyzing the microarray gene chips. The synthesized
biotinylated cRNA molecules were subjected to the Gene Chip sample
cleanup module (Qiagen), fragmented and hybridized with the
Affymetrix Mouse Expression Set 430_2.0 arrays, which contain
around 45,000 mouse transcripts. After washes and an ampliﬁcation
step with streptavidin–phycoerythrin (Molecular Probes) coupled with
the biotinylated anti-streptavidin (Vector Laboratories) antibody, the
bound probes were identiﬁed, their intensity on the microarray slides
being estimated with the Gene Chip Scanner 3000 and quantiﬁed in
relation to a reference target value of 500. The resulting microarray
data sets were analyzed with the Microarray Suite 5.0 program and
the AffyBio conductor package [24,25].
To normalize the data, an RMA function based on a robust
multichip average expression measure [26] was applied. The
statistical analysis was performed in a log base two with a fold
change 41.5 and p-Valueo0.05, which was considered to repre-
sent a signiﬁcant change in the values. The fold change represents
the calculated average value of the replicates of each of the
E X P E R I M E N T A L C E L L R E S E A R C H 3 3 2 ( 2 0 1 5 ) 1 6 3 – 1 7 8 165affymetrix gene data sets generated. The microarray data have
been deposited in the Gene Expression Omnibus (GEO) with the
accession number GSE52730.
For the qPCR, 1 μg of gonad-derived RNAwas converted to cDNA
by a reverse transcription reaction using the ﬁrst strand cDNA
synthesis kit (Fermentas) as suggested by the manufacturer. The
qPCR assays were conducted in three biological replicates from
pooled gonads from different litters.
To analyze expression of the Fst, Notum, Phlda2, Runx1, Dkk1, Cbln1,
Osr2, Dach2, Pitx2, Tacr3 and Msx1 genes, speciﬁc oligonucleotide
primers were designed and synthesized (see Supplementary data
Table I). Two microliters of the cDNA and 0.3 μM of the respective
primers were mixed with the Brilliant SYBRGREEN qPCR master mix
(Stratagene) in a total volume of 10 μl for the PCR reaction cycles. The
MX 3005 P sequence detection system (Stratagene) was used to
analyze the data, and the Gapdh gene was taken as a reference in all
cases. The values were analyzed with Student's t-test and the qPCR
results are presented as means7standard error. The standard error was
around 0.2, and Po0.05 was taken to denote statistical signiﬁcance.
Pair-wise comparisons for identiﬁcation of the Wnt-4-
regulated genes
Although pair-wise comparisons between the genes were per-
formed at the level of the transcripts, multiple entries were also
found for individual genes since there were multiple probes for
some of the genes depicted in the lists.
By analogy with the method used by Jameson [20], we adopted
single or multiple pair-wise comparisons between the samples as a
mean of extracting the genes of interest from the data sets. A p-Value of
0.05 and a cutoff of 1.5 or 2 for the fold change in the microarray were
selected as criteria for signiﬁcance. When multiple pair-wise compar-
isons were performed, the genes indicated as undergoing changes in
many of the array data sets were selected for further studies.
We used the following pairwise comparison criteria to identify
the genes that were enriched in either of the sexes and common
to both of the developmental stages: 1) the gene was expressed at
a higher level in the Wnt-4/ ovary than in the WT at E12.5, and
2) the values for relative expression at E14.5 were in the same
range. Similar criteria were employed to identify the male genes
that showed lineage-speciﬁc depletion.
Correspondingly, the following pairwise comparison criteria
(with the cut offs depicted above) were used to identify genes
enriched in a sex-speciﬁc manner: 1) the gene was expressed at a
higher level in WT ovary than in the WT male at E12.5 (i.e. sex-
speciﬁc expression), and 2) the gene was expressed at a higher
level in the Wnt-4/ female gonad than in the WT female
embryonic gonad at E12.5 (i.e. female-speciﬁc expression).
The genes which overlapped between E12.5 and E14.5 were
considered to represent the true Wnt-4 signalling targets. We adopted
the same strategy to identify the genes which are enriched in the
testes and included a p-Value40.05. To identify whether a gene
identiﬁed as differentially expressed in the Wnt-4-deﬁcient females
and males represented either stromal or germ cell expression, the data
sets generated at E12.5 were compared with those of Jameson et al.
In situ hybridization methods
The non-radioactive section in situ hybridization and the whole-
mount in situ hybridization techniques were performed asdescribed [8]. The cDNA probes were obtained as gifts from the
following persons; Fst (Sergei Tevosian, USA), Dkk1 (Sarah Millar,
USA), Pitx2 (Martin Blum, Canada), Runx1 (Ditsa Levanon, Israel),
Osr2 (Jiang Rulang, USA), Dach2 (Graeme Mardon, USA), Tnfrsf19
(Marja Mikkola, Finland), Msx1 (Image ID 4923403), Cbln1 (Image
ID 5684648), Tacr3 (Image ID 30436441), Notum (Image ID
5125723) and Phlda2 (Image ID 5042041). A minimum of three
WT and three Wnt-4/ gonad pairs were examined with each
gene probe.
Ex vivo gonad organ culture and culture of their
dissociated cells as reaggregates
A disaggregation/reaggregation assay was used to ascertain in
more detail whether the Wnt-4 signal would regulate some of the
genes identiﬁed as the major ones changed due to Wnt-4 knock-
out. The cultures were set up according to Bowles et al. [27] on
WT and Wnt4/ mice. The signalling capacity of Wnt-4 was also
analyzed in whole embryonic gonad cultures in the presence and
absence of 100 ng/ml of the Wnt-4 recombinant protein (R&D
system). The reaggregates were cultured for 48 h and frozen until
used for RNA extraction as described above.
Nuclear extract and electrophoretic mobility shift assay
(EMSA)
Mouse ovary-derived KK1 granulosa cell line was maintained in
DMEM supplemented with antibiotics and serum (10% FBS, Sigma).
Nuclear extracts were prepared from KK1 cell line using the NE-PER
Nuclear and Cytoplasmic Extraction reagents (Thermo Scientiﬁc). The
sequences of the Runx-1 oligonucleotides were designed on the Runx-
1 mouse DNA and were used for the EMSA experiment: TCAC-
TACCTCTTTTCTTCTCAAAGAGCCTGGGATGCTGACAGC (oligo 1), CAAC-
TACTGAAGCTGATTTTCAAGGCTACTTAAAAAAAAAAAAACTGC (oligo 2),
AGCACGCGTGACTCTTATCTTCAAAGGTCTCCCCTGCATGGCAGA (oligo
3), TCACTCTGGATGCCTCCCTTCAAAGTAACCGTTGGAACAGTGAC (oli-
go 4), CTAAAGCTTTGGCTTACACGTCAAAGGGAAATTAGGCCAACTCCTG
(oligo 5), AGTTCTCCCACTTTAGCAAATCAAAGACTCAGAGAGAAAGAA
CCTC (oligo 6). We also used oligonucleotides which contained
mutations in the potential binding sites: CAACTACTGAAGCTGATT
TTCTTGGCTACTTAAAAAAAAAAAAACTGC (oligo 2 mutated) and AGC
ACGCGTGACTCTTATCTTCTATGGTCTCCCCTGCATGGCAGA (oligo 3 mut
ated). Equal amounts of complementary biotin-labelled oligonucleo-
tides were annealed and used in LightShift chemiluminescent EMSA
assay (Thermo Scientiﬁc). For competition analysis, a 200-fold molar
excess of unlabelled annealed oligonucleotides was added. For super-
shift analysis, 2 ml of anti-Tcf-1 antibody (C63D9) (Cell Signalling) or
2 ml of anti-Sf-1 (Steroidogenic Factor 1) antibody (Abcam) were
added to the EMSA reaction followed by incubation at RT for 40min.
Electrophoresis was then performed with a 6% non-denaturing
polyacrylamide gel in TBE buffer. After electrophoresis the biotin-
labelled DNA was electrophoretically transferred to a nylon mem-
brane and then detected using a nucleic acid detection module
(Thermo Scientiﬁc).
Immunohistochemistry
For the immunohistochemical studies, testes and ovaries at the
stages indicated in the results section were prepared, dipped into
a 30% sucrose solution at room temperature for 15 min, mounted
Table 1 – Expression of certain genes in the ovaries at two stages in development: microarray comparison between Wnt-4 /
females and WT females.
ID FC E 12.5 FC E 14.5 Gene symbol Gene name
1421365_at 13.57 6.07 Fst Follistatin
1423635_at 2.47 2.68 Bmp2 Bone morphogenetic protein 2
1420425_at 3.05 Prdm1 PR domain containing 1, with ZNF domain
1415854_at 2.29 Kitl Kit ligand
ID, identiﬁcation; FC, fold change; E, embryonic stage.
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sections. Thereafter the dried samples were stained with rabbit
anti-Mvh antibody (Abcam, 1:200), rabbit anti-Runx-1 (Abcam, 1:
200), rabbit anti-Laminin (Abcam 1:250) or mouse anti-γH2AX
antibodies (Millipore, 1:250). The corresponding Alexa Fluor-
conjugated anti-mouse and anti-rabbit antibodies (Invitrogen)
served to identify the bound primary antibody.Bioinformatics analysis
The lists of up-regulated and down-regulated genes obtained
from the microarray analysis at E12.5 and E14.5 were classiﬁed
into speciﬁc categories using the Funnet program (http://www.
funnet.info), which is an integrative functional genomics tool with
annotations based on Gene Ontology and Kyoto Encyclopaedia of
Genes and Genomes pathways.
We used the Ensemble programme to assess whether the Runx-
1 gene had TCF binding sites, as this enabled comparison and
multiple sequence alignments. Four mammalian sequences were
employed: Mus musculus, Gorilla gorilla, Homo sapiens and Pan
troglodyte. The possible presence of putative conserved sequences
mediating the binding of the Tcf-1 to the DNA (TCAAAG) and for
Sf-1 (TCAAGGCTA) was screened from the Runx-1 locus in silico.Results
Absence of Wnt-4 leads to changes in stage-speciﬁc gene
expression in the embryonic gonad
The organogenesis of the mammalian gonad depends on the
signals which are synthesized by the somatic, germ and meso-
nephric cells. Wnt-4 is one crucial factor, since it is expressed in
the somatic cells and its absence is characterized by a partial
female-to-male sex reversal [5,7]. Thus Wnt-4/ male and
female embryos should provide a way of identifying a wealth of
genes which are involved in the mammalian primary sex deter-
mination events and soon afterwards [9,6,28].
At E12.5, the fate of the gonad is determined to be either a testis,
due to the Sry expression at E11.5, or an ovary due to Wnt-4 or
Rspo-1 expression. At E14.5, the germ cells entered meiosis in the
females, and they ceased mitotic cell divisions in the males. A
deﬁciency in Wnt-4 function may inﬂuence the somatic and germ
cells of both sexes at E12.5 and E14.5 [5,7–9]. Given this, we set out
to identify the putative Wnt-4 signalling target genes and prepared
gonads from Wnt-4þ/ litter mates at these two speciﬁc develop-
mental stages. Total RNA was extracted, processed and subjected to
affymetrix gene chips to assess potential changes in the transcrip-
tome between the gonads of the Wnt-4/ and WT embryos.To test the feasibility of the approach, we set out ﬁrst to
determine from the microarray data whether any of the genes
implicated in ovary development had been deregulated by the
Wnt-4 deﬁciency. As expected, the expression of Fst (Follistatin), a
down-stream target of Wnt-4 signalling [29], Bmp2 (Bone morpho-
genetic protein 2) [29], a regulator of Fst, and Kitl (Kit ligand) a
survival factor for female primordial germ cells [30], were notably
down-regulated relative to the controls (Table 1). We regard this as
evidence that the approach is a feasible one for reliably detecting
genes in the embryonic gonad which are regulated by Wnt-4.Identiﬁcation of candidate genes for female development
by in silico subtraction of the microarray data
Of the 45,000 probes analyzed, the expression of only 101 genes
at E12.5 and 93 genes at E14.5 was increased signiﬁcantly by more
than 1.5 fold as compared with the controls due to Wnt-4 knock-
out (Fig. 1A, Supplementary Tables II–V). Similarly, 75 genes at
E12.5 and 137 at E14.5 were down-regulated in the Wnt-4-
deﬁcient ovaries (Fig. 1A, Supplementary Tables II–V).
Interestingly, eleven out of the 176 genes which were up or
down-regulated by more than 1.5-fold in the Wnt-4/ ovary at
E12.5 were to be found among the 220 such genes identiﬁed at
E14.5. Fst was one of these [29], or the Tnfrsf19 (Tumour necrosis
factor receptor superfamily member 19) and Wnt-4 genes, as
expected (Fig. 1B).
We next used the microarray data to highlight those genes
which were enriched in the individual key cell types of the gonad:
supporting interstitial/stromal cells, germ cells and endothelial
cells [20]. The aim was to reveal in what cell types Wnt-4 would
regulate the genes characterized here. In silico comparison
revealed that Wnt-4 affects substantially different gonadal gene
sets at E12.5 and E14.5 (Fig. 1B).
We went on to classify by means of the Funnet program those
genes that were most notably changed by the absence of Wnt-4
signalling based on the function demonstrated for them. The
approach showed that at the developmental stages studied here,
compromised Wnt-4 signalling largely inﬂuenced genes in cate-
gories such as nuclear factors, extracellular matrix (ECM) proteins
and plasma membrane associated proteins (Supplementary Fig. 1A
and B). Hence Wnt-4 signalling has a profound effect on its target
cells, from the ECM all the way to the nucleus, when its function is
impaired.
One of our goals was to ﬁnd novel candidate functional genes for
the female sexual developmental pathway. This was done by means
of pair-wise comparisons, focusing ﬁrst on those genes whose
expression was higher in the WT ovaries than in the WT testes at
E12.5 and E14.5 (Fig. 1C and D). This comparison was expected to
reveal the genes which are enriched in the early ovary. In addition,
Fig. 1 – The selected pool of genes which are regulated speciﬁcally in the embryonic ovary. (A) Number of genes expressed in
ovaries which have an expression signal that shows a statistically signiﬁcant increase or decrease of 1.5 fold between theWnt-4 /
and WT ovaries at stages E12.5 and E14.5. (B) Venn diagram illustrating the overlap in the number of signiﬁcant genes that are
differentially expressed between Wnt-4 / and WT ovaries at stages E12.5 and E14.5. (C) Venn diagram illustrating the overlap in
the number of signiﬁcant differentially expressed genes between WT ovaries and testes as compared with Wnt-4 / and WT
ovaries at E12.5. Phlda2whole mount in situ hybridization forWnt-4 /and WT ovaries and WT testes conﬁrmed the results of the
comparison. (D) Venn diagram illustrating the overlap in the number of signiﬁcant differentially expressed genes between WT
ovaries and testes as compared withWnt-4 / and WT ovaries at E14.5. Tnfrsf19whole mount in situ hybridization for theWnt-4 /
, WT ovaries and WT testes conﬁrmed the results of the comparison. (B, C, D) The common genes summarized in the tables were
compared as described in Material and Methods and with previous data [20] in order to determine the speciﬁc cell type in which
the gene is expressed. Non-speciﬁed depicts herein that the gene has not been signed to a speciﬁc lineage. WT, wild type; MT,
mutant. Scale bar (C–D) 100 μm.
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and half-fold at E12.5 and E14.5 with those that were expressed
differentially between theWnt-4 / and WT ovaries (Fig. 1C and D).
Such in silico subtraction would highlight better those genes which
may prove relevant for ovary development in the end.
Comparison of the transcriptome between the WT ovaries and testes
identiﬁed a set of 95 genes whose expression was increased more than
two-fold at E12.5 and 89 genes at E14.5 (Fig. 1C and D; red circles). When
the transcriptome of the Wnt-4 deﬁcient ovaries was compared with the
one derived from theWTovaries, only 75 and 137 down-regulated genes
(1.5-fold) were identiﬁed, respectively (Fig. 1C and D; yellow circle).
We went on to compare the data obtained from the two compu-
ted data sets at E12.5 and E14.5 (Fig. 1C and D; intersections of the red
and yellow circles). Interestingly, these comparisons revealed only
ﬁve genes at E12.5 and ﬁve genes at E14.5 whose expression had
altered signiﬁcantly between the data sets. One of these was theFig. 2 – Expression proﬁles of candidate genes involved in the early
Runx1 and Msx1 gene expression was analyzed in WT ovaries and t
E12.5 by section in situ hybridization. Expression of all these genes
Scale bar (A–Y) 100 μm. WT wild type; MT mutant.above-mentionedWnt-4 signalling target Fst and the others were Irx3
(Iroquois 3), Phlda2 (Pleckstrin homology-like domain, family A, member
2), Bmp2, and Adamdec1 (ADAM-like, decysin1) at E12.5, and Irx3, Fst,
Acsm3 (acyl-CoA synthetase medium-chain family member 3), Calb1
(Calbindin-1) and Tnfrsf19 at E14.5. The WT testis did not express the
Phlda2 and Tnfrsf19 genes, but the WT ovarian cells did. Expression
was reduced in the absence of Wnt-4 in the female, as expected,
which is in line with the microarray data depicted also with whole
mount in situ hybridization analysis (Fig. 1C and D).
Wnt-4 deﬁciency deregulates expression of a panel of
genes during female sexual development
To conﬁrm the feasibility of the microarray data, we selected
those genes which appeared to be enriched in the ovary and were
illustrative of the female sexual differentiation pathway. Westeps of female sexual development. (A–T) Fst, Notum, Phlda2,
estes and Wnt-4 / ovaries at E12.5 and E14.5, by qPCR and at
was down-regulated in theWnt-4 / ovaries. O, ovary; T, testis.
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in situ hybridization studies (Fig. 2, Supplementary Fig. 2). The Fst
gene was chosen as a positive control since its expression was
high in the WT ovaries but low in the WT testes (Fig. 2A). Indeed,
Wnt-4 deﬁciency notably reduced Fst expression as judged by
qPCR and in situ hybridization, which was consistent with earlier
ﬁndings [29] (Fig. 2A–D).
We then picked the Notum [31], Phlda2, Runx1 (Runt-related
transcription factor 1, [32] ), andMsx1 (Homeobox, msh-like 1, [33])
genes for closer studies. The β-catenin/TCF complex, for example,Fig. 3 – The selected pool of genes which are regulated speciﬁcally i
which have an expression signal showing a statistically signiﬁcant
testes at stages E12.5 and E14.5. (B) Venn diagram illustrating the
genes between Wnt-4 / and WT testes at stages E12.5 and E14.5.
signiﬁcant differentially expressed genes between WT testes and o
whole mount in situ hybridization for Wnt-4 / and wild-type te
comparison. (D) Venn diagram illustrating the overlap in the num
testes and ovaries as compared with Wnt-4 / and WT testes at E
compared as described in Material and methods and with previous
the gene is expressed. Non-speciﬁed depicts herein that the gene h
mutant. Scale bar (C) 100 μm.interacts with the Notum promoter to regulate gene expression
[31], making it an interesting putative Wnt-4 target. Notum is
indeed expressed normally in the embryonic ovary, but its
expression was down-regulated at E12.5 (Fig. 2E) in the absence
of Wnt-4 function (Fig. 2E and F–H). Similarly, the ovarian
expression of the Phlda2 and Runx1 genes was down-regulated
in the absence of Wnt-4 function (Fig. 2I and M), as also shown by
in situ hybridization (Fig. 2J–L and N–P).
Of the genes studied here, Msx1, which encodes a transcription
factor, is implicated in meiosis [33] and is expressed in the ovaryn the embryonic testes. (A) Number of genes expressed in testes
increase or decrease of 1.5 fold between Wnt-4 / and WT
overlap in the number of signiﬁcant differentially expressed
(C) Venn diagram illustrating the overlap in the number of
varies as compared with Wnt-4 / and WT testes at E12.5. Cer
stes and wild type ovaries conﬁrmed the results of the
ber of signiﬁcant differentially expressed genes between WT
14.5. (B, C) The common genes summarized in the tables were
data [20] in order to determine the speciﬁc cell type in which
as not been signed to a speciﬁc lineage. WT, wild type; MT,
E X P E R I M E N T A L C E L L R E S E A R C H 3 3 2 ( 2 0 1 5 ) 1 6 3 – 1 7 8170at E12.5 and E14.5. Consistent with our microarray data, Msx1
expression was lower in the Wnt4 / ovary, as judged from the
in situ hybridization studies (Fig. 2Q–T).
Comparison of our data sets with those of Jameson et al. (2012)
indicates that Phlda2 and Msx1 represented the germ cell genes
while Fst, Notum and Runx1 were typical of the somatic cells
(Fig. 2A–T and Supplementary Fig. 2). In conclusion, our data
indicate that Wnt-4 signalling controls not only the genes in
gonadal somatic cells, but also those in germ line cells.Wnt-4 signalling also controls the genes associated with
the male sexual development pathway
Wnt-4 was characterized initially as a female sex determinant
which inhibits the male developmental programme in female
embryos [5]. Besides this key role, however, Wnt-4 has also been
considered to take part in the control of testis organogenesis
[9,10,34,35]. Thus we made use of the microarray data to extract
putative Wnt-4-dependent genetic changes in the male embryo-
nic gonad as well.
The genes expressed in the testes of the Wnt4 / embryos
were compared with those in WT testes at E12.5 and E14.5,
focusing on those genes which are induced or repressed by more
than 1.5-fold.
The in silico comparison highlighted 111 genes that were up-
regulated at E12.5 and 18 at E14.5, while 36 and 29 genes, resp-
ectively, were repressed in the early testis (Fig. 3A, Supp-
lementary Tables VI–IX). The Igfbp3 (Insulin-like growth factor binding
protein 3, [36]) and Col14a1 (Collagen 14a1, [15]) genes represent ones
that are induced (Supplementary Tables VI–IX) and are involved in
testis development [36,15]. Categorization of the Wnt-4 regulated
genes to functional classes revealed similar groups to those noted in
the female embryos (Supplementary Fig. 1, compare D with C).
We then assessed whether any of the genes were common to
the sets depicted at E12.5 and E14.5, so that they could be seen to
have been either up or down-regulated (Fig. 3B). Unexpectedly,
the comparison revealed only three genes: 8030451F13 Rik, Prrx1
(Pair-related homeobox 1) and Cbln1 (Cerebellin 1 precursor pro-
tein) [18] (Fig. 3B, Supplementary Tables VI–IX).
We also made pair-wise comparisons to extract in more depth
data that might identify other possible candidates for testis
organogenesis and point to genes which were two-fold higher
in the WT testes than in the WT ovary. We also looked for genes
with one and half-fold reduced expression in the Wnt-4 / testes
than in the WT testes at E12.5 and E14.5 (Fig. 3C).
The analyses highlighted only Cbln1 as a differentially expressed
gene at E12.5 (Fig. 3C), and two genes Akr1b7 and Foxf1a at E14.5
(Fig. 3D). Consistent with this ﬁnding, the Cbln1 gene was expressed
in the WT testis but not in the WT ovary, and its expression was
reduced in theWnt-4 deﬁcient testes (Fig. 3C). We conclude that the
genetic programming behind testis and ovary development involves
genes that are stage-speciﬁcally regulated by Wnt-4.
To substantiate our ﬁndings, we selected a panel of genes which
appeared to be differentially expressed on the basis of the
microarray data for qPCR and the in situ hybridization analysis.
Dkk1 (Dickkopf homologue 1) served as a control as it is enriched
in the embryonic testis [37,38]. It was in fact robustly expressed in
the WT embryonic testes, not detected in the WT ovaries, and
reduced in the Wnt-4-deﬁcient testes (Fig. 4A–D, SupplementaryFig. 2K and L). We speculate that Dkk1 may suppress the female
properties of Wnt-4 in the embryonic testis.
We also showed that the Cbln1 [18], Osr2 (Oscar-2), Tacr3
(Tachychin receptor 3), Pitx2 (Paired-like homeodomain transcrip-
tion factor 2), Dach2 (Dachshund homologue 2) [39–42] genes were
enriched in WT embryonic testes. Cbln1, for example, which is
expressed in interstitial cells (Fig. 4E–H) was reduced in the
absence of Wnt-4 (Fig. 4H), as it is also the case with the Osr2 and
Tacr3 genes (Fig. 4I–L and M–P).
We then examined those genes which were absent from the
WT ovaries but highly expressed in the WT testes, with reduced
expression in the absence of Wnt-4 function in the male. Pitx2
(Fig. 4Q–T) and Dach2 serve as examples of such genes in the
seminiferous tubules (Fig. 4U–X). Taken together, we consider our
ﬁndings to support the conclusion that Wnt-4 is indeed func-
tional in the testis, having an intrinsic role in the coordination of
its organogenesis.
Wnt-4 and Runx-1 expression patterns are mutually
interdependent in the embryonic ovary
Given the important role of Runx-1 in the development of the
aorta-gonad-mesonephros (AGM) region [22],its expression in
granulosa cells [43,44] and its reduced expression in Wnt-4 /
ovaries (Fig. 2M–P, Supplementary Table III), we focused our
attention on Runx-1.
The data indicate that the Runx-1 gene is expressed in the early
ovary and is not detected in the testis (Fig. 2M–P). The in situ
hybridization analysis highlighted Runx-1 expression in the ovarian
somatic cells and a considerable decrease occurred relative to the
controls in the absence of Wnt-4 (Fig. 5A–C). Thus Runx-1 expres-
sion depends on Wnt-4 function and could indeed represent a true
Wnt-4 signalling target and was examined directly.
We ﬁrst performed an in silico analysis to determine whether the
Runx-1 gene contained any conserved binding sites for the TCF
transcription factor, a key mediator of the canonical Wnt signal
transduction pathway. Comparison of four mammalian Runx-1
sequences revealed ﬁve potential conserved sites (Fig. 5D) in the
locus, in line with the possibility that Runx-1 might indeed be
regulated by the Wnt signalling pathway. Also one steroidogenesis
factor 1 (SF-1) binding site was found. To conﬁrm the potential
Tcf-1 and binding sites, we used a mouse ovarian granulosa cell
line (KK1) which is immortalized luteinizing granulosa cells [45].
The binding of nuclear proteins to oligonucleotide probes
spanning the potential TCF1-binding sites was examined by
EMSA. The oligonucleotides 1, 4, 5 and 6 did not demonstrate
any signal shifts when they were combined with nuclear extracts
from KK1 cell line, whereas oligonucleotides 2 and 3 formed
protein–DNA complexes (S1 and S2) (Fig. 5E). Mutated oligonu-
cleotides, which contained mutations in the potential binding
sites 2(Sf-1)and 3(Tcf-1), were used in EMSA reactions. The
nuclear protein binding to the oligonucleotide 3 did not depend
on the presence of intact TCF1 binding site. On the other hand,
mutated variant of oligonucleotide 2 did not bind any transcrip-
tion factors in EMSA assay. The production of oligonucleotide 2-
speciﬁc complex was prevented by competition from an excess of
corresponding non-labelled DNA probe. Moreover, anti-Tcf-1 anti-
body almost completely prevented the formation of the DNA–
protein complexes, indicating that Tcf-1 may bind the Runx-1
gene directly at T2 site (Fig. 5E). We also used an antibody against
Fig. 4 – Developmental changes in the expression of a panel of genes during early male sexual development. (A–X) Changes in expression
of the Dkk1, Cbln1, Osr2, Tacr3, Pitx2 and Dach2 genes were analyzed in embryonicWTovaries and testes andWnt-4 / testes at E12.5 and
E14.5 by qPCR and at E12.5 by in situ hybridization. O, ovary; T, testis. Scale bar (A–X) 100 μm. WT, wild type; MT, mutant.
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antibodies were combined the complex was completely reduced
preventing the formation of DNA–protein complex with oligonu-
cleotide 2 (Fig. 5E). This result indicates that Tcf-1 and Sf-1 might
work synergistically to bind on the Runx-1 gene.
After obtaining these data, we went on to the in vivo studies
with Runx-1 knock-out mice. Runx-1 knock-out leads to anaemiaand is lethal at around E12.5 [22], precluding any straightforward
use of this model to address the roles of Runx-1 in the control of
Wnt-4 expression. Prior to the in uteri death of the Runx-1 /
embryos, however, Wnt-4 expression in the somatic embryonic
ovarian cells was similar to the WT ovary (Fig. 6, compare B with
A), but no Wnt-4 expression was observed in embryonic male
cells (Fig. 6C).
Fig. 5 – In silico analysis of TCF binding sites on the mammalian Runx-1 gene. (A, B, C) Immunohistochemistry of Runx-1 in WT and
Wnt-4 / ovaries and WT testes. (D) Runx1 contains four isoforms (splice variants 1, 2, 3 and 4) which are common to the four
selected mammalian sequences. We found ﬁve conserved TCF and one SF1 binding sites in the Runx-1 gene. (E) EMSA analysis of
the potential binding sites on the Runx-1 gene. Nuclear extracts, unlabelled control oligonucleotides, anti-Tcf-1 and anti-Sf-1
antibodies were added to the binding reactions as indicated. S1 and S2 – shifted bands for oligonucleotides 2 and 3,
correspondingly. Scale bar (A–C) 100 μm.
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ciency, we made use of yet another mouse model in which the in
utero deﬁciency is rescued by targeted expression of the Runx-1
gene in the embryonic endothelial cells [22]. We crossed Runx-1
ﬂoxed mice with Tie2-Cre ones, thereby rescuing this Tie2Cre;
Runx1Rev/Rev cross from the embryonic lethality of the Runx-1
knock-out [23].The targeted endothelial Runx-1 gene expression in the Tie2Cre;
Runx1Rev/Rev knock-out background did not, however, rescue theWnt-
4 gene expression in the embryonic ovary (Fig. 6, compare E with D),
looking similar to the WT testes (Fig. 6F). Since meiosis entry is
compromised in the absence of Wnt-4 signalling, we assessed the
fate of meiosis in these embryos using the γH2AX protein as a meiosis
marker [8]. γH2AX protein expression was reduced to some extent in
Fig. 6 – Expression ofWnt-4 in the Runx-1-deﬁcient ovary. (A–F)Wnt-4 expression was down-regulated at E12.5 of the Runx-1 knock-
out female embryos and at E14.5 in the ovaries of the Tie2-Cre;Runx1Rev/Rev crossing. (G-I) Germ cells are identiﬁed with anti Mvh
antibodies (in green) and meiosis with anti γH2AX antibodies (in red), which denote the germ cells of the wild-type and Tie2-Cre;
Runx1Rev/Rev deﬁcient embryonic ovaries. Note that the germ cells of normal testes do not express γH2AX. (J, K) Depiction of Laminin
expression pattern in WT and Runx-1 / ovaries. Scale bar (A–F) 250 μm, (G–K) 200 μm. O, ovary; T, testis. WT, wild type; MT, mutant.
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by endothelial retargeted expression of the Runx-1 gene. The anti-
Vasa immunostaining suggested that germ cells were present in
related intensities in the ovaries of the Tie2Cre;Runx1Rev/Rev and WT
embryos (Fig. 6G–I). We conclude that the Runx-1 and the Wnt-4
signalling pathways are mutually interdependent in the ovary. To
further analyze the Runx-1 ovary fate, laminin staining was per-
formed. The ovaries of the Runx-1/ females demonstrated
seminiferous-like peritubular laminin expression and the ovary
appeared more round in shape and differed in this respect from
WT ovary at this stage (Fig. 6J and K).
Wnt-4 signalling enhances Runx-1 expression in the
embryonic gonad ex vivo
Given the mutual dependence of Runx-1 and Wnt-4 expression,
we applied the ex vivo experimental approach to determine insuch a setting whether Wnt-4 would regulate Runx-1 expression.
The classic embryonic gonad cell dissociation and reaggregation
technology was employed for this purpose [46]. In this case the
Wnt-4 signal, which normally shows poor diffusion in tissues, due
in part to Wnt binding to the heparan sulphate of the extracellular
matrix and the cell surface proteoglycans, is exposed to gonadal
cells in its close proximity.
We dissected the embryonic ovaries out at E12.0 and disso-
ciated the constituent cells after treatment with a mild enzyme,
washed them and reaggregated them in the presence or absence
of the Wnt-4 recombinant protein. Dissociation and reaggregation
of the primary embryonic gonadal cells with or without the Wnt-
4 protein, together with a 48-hr sub-culture of the reconstituent
caused some degree of recovery of the gonadal structure, since
germ cells, presumptive germ-line nest in female and seminifer-
ous tubule-like structures in male were noted (Fig. 7A and data
not shown).
Fig. 7 – Recovery of candidateWnt-4 target genes uponWnt-4 gain of function in the reconstituted organotypic gonadal model. (A)
Histology of the reaggregates after prior dissociation of gonadal cells obtained from wild-type female and male embryos at E12.5,
cultured for 48 h and shown in the form of a high power micrograph of a pellet of reaggregated cells. (B–G) Anti-Mvh antibody-
mediated staining of a germ cell (in green). The anti-γH2AX antibodies (in red), indicating meiosis in the germ cells, are expressed
throughout the ovaries of the wild-type embryos cultured for 48 h, but γH2AX is not expressed by the embryonic testicular germ
cells. (H) Histograph illustrating Runx1, Fst and Wnt-4 gene expression in CD1 gonadal and liver cells which had been dissociated
and reaggregated alongside the Wnt-4 recombinant protein and subcultured for 48 h. (I) Histograph illustrating Cbln1, Runx1, Fst
andWnt-4 gene expression inWnt-4 gonadal cells which had been dissociated and reaggregated alongside the Wnt-4 recombinant
protein and subcultured for 48 h. Scale bars: (A) 50 μm and (B–G) 100 μm. WT, wild type; MT, mutant.
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the germ cells had regenerated their capacity to initiate meiosis
even after dissociation and reaggregation of the ovarian cells
(Fig. 7B–D) [47]. The γH2AX meiosis marker was not expressed in
similar reaggregates produced from embryonic testis, as expected
(Fig. 7E–G). We conclude that this set-up also provided a way of
addressing the roles of Wnt-4 signalling in the control of Runx-1
and Fst expression.
The presence of Wnt-4 protein in the dissociated and recon-
stituted gonad auto-induced its own gene expression, in line with
ﬁndings in the embryonic kidney [48] (Fig. 7H). The presence ofWnt-4 signalling in the reaggreates induced expression of the Fst
and the Runx-1 genes as compared with the controls (Fig. 7H). The
liver, which also contains Runx1, served as a negative control here
[22] (Fig. 7H). To conﬁrm the data obtained from the CD1 mice,
we generated similar reaggregates using the Wnt-4 mice (Fig. 7I).
One male gene Cbln1 was added in the assay which is expressed
in WT males and Wnt-4 / females. By supplementing Wnt4
protein into the medium, Cbln1 expression was reduced in both
WT males and Wnt-4 / females, suggesting that Wnt4 signals
rather directly to control the expression of these selected
genes (Fig. 7I). Runx-1 and Fst expression was increased in the
E X P E R I M E N T A L C E L L R E S E A R C H 3 3 2 ( 2 0 1 5 ) 1 6 3 – 1 7 8 175reaggregates in all genotypes (Fig. 7I). These data reinforce the
conclusion that the functions of Runx-1 and Wnt-4 are well
coordinated by their own activities to advance the developmental
programme that leads to assembly of the ovary.Discussion
Mammalian sex determination and the putative Wnt-4
gonadal target genes
The mammalian gonad is initially indifferent, but around mid-
gestation it is directed to follow either the male or the female
sexual development pathway, i.e. to form testes or ovaries.
Consequently, considerable interest has been shown in identifying
the genes involved during these critical developmental stages.
Since Wnt-4-deﬁcient female embryos undergo a partial sex
reversal and adopt certain critical male characteristics, Wnt-4
serves as good model for depicting the genes involved in the early
sexual development of female and male embryos.
Applying microarray technology, we did indeed identify Wnt-4-
dependent changes in Fst and Dkk1 expression. Fst has been
shown to take part in the Wnt-4-regulated early female sexual
development steps [29], while Dkk1 takes part in the control of
organogenesis in the testes [37,38]. We therefore considered that
the approach selected here faithfully depicted those genes that
are relevant for early gonad development.
The strategy of comparing genes which are differentially
expressed between wild type and the Wnt-4/ ovaries, and
correspondingly the testes, at E12.5 and E14.5, revealed a panel of
candidate Wnt-4-related genes. Based on these results, we spec-
ulate that, apart from having a role in female sex organogenesis,
Wnt-4 signalling is also involved in early testis development, a
fact which warrants further investigation.
Out of the list of 50 genes that were altered most in the absence
of Wnt-4 function, we focused on eleven genes for which earlier
data had suggested an association with Wnt signalling, sex
determination/differentiation and the hormone synthesis path-
ways. Among these, the Fst, Phlda2, Dkk1, Cbln1, Osr2 and Pitx2
genes were of particular interest, since they have been considered
in the light of earlier microarray studies to be potential gonad
development genes [18,32,12,11,49]. The Notum, Msx1, Dach2,
Tacr3, and Runx1 genes were selected for further study due to
the robustness of the changes in their expression in the absence of
Wnt-4 signalling. These genes may be considered to represent part
of the characteristic signature of ovary and testis development and
as such may serve to highlight the developmental programme that
directs the indifferent gonad to construct either an ovary or a testis.
Whether the identiﬁable parts of such gonadal signature genes
indeed function directly as a cascade in the female and male Wnt-
4-controlled gonad development programmes remains to be seen.
The Notum and Dach2 genes encode proteins that serve as
antagonists of the Wnt signalling pathway in the ﬂy and the
planarians [50,51]. Notum expression was reduced by Wnt-4
knock-out and it may ﬁne-tune Wnt-4 signalling in the ovary
and serve as a Wnt-4-dependent antagonist to the Wnt-4 signal.
In the ﬂy, the Dach2 and Wnt-4 functions are connected [42].
Dach2 expressed in the endothelial cells signals to the adjacent
dorsal ectodermal cells to regulate Wnt-4 expression during myo-
genesis. As Dach2 expression is down-regulated in the absence ofWnt-4 in the mammalian gonad, this may suggest the existence of a
Wnt-4-dependent antagonist which would normally express Dach2.
Our earlier work demonstrated that the absence of Wnt-4
signalling changes the expression of the Sypc1, Sypc3, Msh5,
Spo11 and Stra8 genes and that the entry of germ cells into meiosis
was severely compromised [8]. The Msx1 gene triggers meiosis in
female germ cells in synergy with retinoid acid and Stra8, a key
meiosis entry factor [33]. Since Wnt-4 provides a critical signal for
meiosis control [8], the identiﬁcation of Msx-1 as a putative Wnt-4
signalling target gene may represent a hallmark of how Wnt-4
signalling contributes to meiosis control in mammals.
Of the Wnt-4-regulated genes, the Tacr3 gene product is
connected to the tachykinin pathway. Since Tacr3 function is
involved in the hypothalamic-pituitary-gonadal axis, which also
involves Wnt-4 function, we selected Tacr3 for further study.
Tacr3 is a G protein-coupled receptor which is expressed by the
Leydig cells in the testis [52]. Since Wnt-4 deﬁciency induces
ectopic androgen-producing Leydig cells [7], Tacr3 expression in
the Wnt-4-deﬁcient gonad may be another indication of the
ectopic activation of the male programme for controlling genes
which are normally inhibited by Wnt-4 signalling in the female
gonad. Thus the Wnt-4 signal may normally inhibit Tacr3 gene
expression in the early ovary to promote the female sex determi-
nation process regulated by Wnt-4 [5].
Runx-1 as a target gene for Wnt-4 signalling with putative
roles in ovary development
The Runx genes encode critical transcription factors in several
biological processes [53]. Runx1, also known as Acute Myeloid
Leukaemia 1 (AML1), regulates haematopoietic stem cells in the
aorta-gonad-mesonephros (AGM) region [22]. The Runx1 gene is
present in the chromosomal region that undergoes translocation
in association with leukaemia, for example. This suggests that
Runx-1 regulates cell differentiation and transformation when it is
hit by a mutation [53]. Besides the AGM, the Runx-1 has also been
localized to the granulosa cells [54], and changes in its expression
correlate with the maturation of the female follicle during the
menstrual cycle, with a peak during ovulation [44].
Since Runx-1 transcripts appear in the mouse gonad after the sex
determination stages [11], we speculated that Runx-1 would be a
suitable Wnt-4 signalling target. Runx-1 controls cell proliferation
and cell differentiation during intra-embryonic haematopoietic
system development in the mouse [55] and Wnt-8 similarly induces
Runx-1 in the haematopoietic stem cells of the zebraﬁsh [56]. We
found here that Wnt-4 expression is substantially reduced in the
Runx-1-deﬁcient ovary, and that Runx-1 expression was reduced in
the absence of Wnt-4 function. We found one Tcf-1 and one Sf-1
binding sites on the Runx-1 gene. ChIP-seq data from Wu et al. [57]
showed that TCF-7, also known as Tcf-1, bind onto the Runx-1 gene
at several places in the mouse multipotential hematopoietic cell line,
demonstrating interactions between TCF-1 factor and Runx-1 gene.
Moreover, Wnt-4 gain-of-function induced Runx-1 expression in
embryonic gonadal cell reaggregates in WT and in Wnt4/ female.
Collectively these data reinforce the conclusion that these two
components are mutually dependent on each other's activity.
Indeed, TCF1 (Lef1) binds to the Runx2 regulatory sequences in
osteoclasts that bring about promoter regulation in a ß-catenin-
dependent manner [58]. Based on these ﬁndings and the presence
of functional Tcf and Sf-1 binding sites in the Runx-1 gene, we
E X P E R I M E N T A L C E L L R E S E A R C H 3 3 2 ( 2 0 1 5 ) 1 6 3 – 1 7 8176speculate that Tcf-1 may indeed synergize to coordinateWnt-4 gene
regulation in the gonad and advance ovary development. The
various Wnt-4 mouse models generated in recent years, such as
Wnt-4Cre, Wnt-4 ﬂoxed and Wnt-4mCherry may serve as good
models for addressing the potential roles of direct target of
secondary Wnt-4 signalling in the control of gonad development.
To summarize, we have identiﬁed a panel of candidate genes which
may contribute to mammalian sex determination, somatic and germ
cell differentiation and the formation of the ovary and testis. This
study has revealed a panel of candidate genes subject to Wnt-4
signalling that may be essential for forming the mammalian gonad.Funding
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